ASR Vermogensbeheer’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$171M Buy
142,153
+3,439
+2% +$3.51M 1.76% 8
2026
Q1
$128M Sell
138,714
-666
-0.5% -$675K 1.5% 10
2025
Q4
$150M Sell
139,380
-11,277
-7% -$10.8M 1.74% 10
2025
Q3
$115M Buy
150,657
+1,197
+0.8% +$891K 1.39% 11
2025
Q2
$117M Buy
149,460
+7,751
+5% +$6.02M 1.51% 9
2025
Q1
$117M Buy
+141,709
New +$118M 1.73% 8

Other funds holding LLY

ASR Vermogensbeheer's LLY Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $3.51M and bringing the position to 142,153 shares worth $171M. The position accounts for 1.76% of the portfolio, ranked #8.

ASR Vermogensbeheer first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,778 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ASR Vermogensbeheer held 142,153 shares of Eli Lilly worth $171M as of Q2 2026.
  • ASR Vermogensbeheer bought 3,439 Eli Lilly shares in Q2 2026, an estimated $3.51M.
  • Eli Lilly made up 1.76% of ASR Vermogensbeheer's portfolio in Q2 2026, its #8 holding.
  • ASR Vermogensbeheer first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,778 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.